The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models

Transfusion

Volumn 50, Issue 7, 2010, Pages 1505-1511

  Fu, Yongshui ^a,b,c,d,e   Xia, Wenjie ^a,b,c,d,e   Wang, Yizhong ^a,b,c,d,e   Tian, Linwei ^a,b,c,d,e   Pybus, Oliver G ^a,b,c,d,e   Lu, Ling ^a,b,c,d,e   Nelson, Kenrad ^a,b,c,d,e  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

5' UNTRANSLATED REGION; ADULT; ARTICLE; BLOOD DONOR; CHINA; ENZYME IMMUNOASSAY; ENZYME POLYMORPHISM; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN EXPERIMENT; MALE; NUCLEIC ACID AMPLIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROPREVALENCE;

ADULT; BLOOD DONORS; CHINA; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 77954339420     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02616.x     Document Type: Article

References (37)

1. World Health Organization. Hepatitis C global prevalence. Wkly Epidemiol Rec 1999 74 : 425 7.
2. World Health Organization. Hepatitis C. Wkly Epidemiol Rec 1997 72 : 65 9.
3. Aymard JP, Botte C, Contal P, Janot C, Treiff F. Seroprevalence of hepatitis C-antibodies among blood donors: study of second generation ELISA & RIBA tests and surrogate markers. Pathol Biol (Paris) 1993 41 : 149 53.
4. Shakil AO, Conry-Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V, Krawczynski K, Conjeevaram HS, Sallie R, Di Bisceglie AM. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med 1995 123 : 330 7.
5. Panigrahi AK, Panda SK, Dixit RK, Rao KV, Acharya SK, Dasarathy S, Nanu A. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver disease. J Med Virol 1997 51 : 167 4.
6. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006 144 : 705 14.
7. Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 2006 45 : 607 16.
8. Alter MJ. Transmission of hepatitis C virus - route, dose, and titer. N Engl J Med 1994 330 : 784 6.
9. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002 36 : S21 9.
10. Zoulim F, Chevallier M, Maynard M, Trepo C. Clinical consequences of hepatitis C virus infection. Rev Med Virol 2003 13 : 57 68.
11. Beach MV. "Blood heads" and AIDS haunt China's countryside. Lancet 2001 357 : 49.
12. Kaufman J, Jing J. AIDS: China and AIDS - the time to act is now. Science 2002 296 : 2339 40.
13. Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, Gao GJ, Ji Y, Ness PM. Blood banking in China. Lancet 2002 360 : 1770 5.
14. Wu Z, Liu Z, Detels R. HIV-1 infection in commercial plasma donors in China. Lancet 1995 346 : 61 2.
15. Xia GL, Liu CB, Cao HL, Li S, Zhan MY, Sub CA, Nan JH, Qi XQ. Prevalence of hepatitis B and C virus infections in the general Chinese population: results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun 1996 5 : 62 73.
16. Lei XZ, Shigeko N, Deng XW, Wang S, Qin S, Liu L, Tang H, Zhao L, Lei B, Yoshihiro A. Prevalence of hepatitis C virus infection in the general population and patients with liver disease in China. Hepatol Res 1999 14 : 135 43.
17. Wang Y, Tao QM, Zhao HY, Tsuda F, Nagayama R, Yamamoto K, Tanaka T, Tokita H, Okamoto H, Miyakawa Y. Hepatitis C virus RNA and antibodies among blood donors in Beijing. J Hepatol 1994 21 : 634 40.
18. Ding X, Gu H, Zhong ZH, Zilong X, Tran HT, Iwaki Y, Li TC, Sata T, Abe K. Molecular epidemiology of hepatitis viruses and genotypic distribution of hepatitis B and C viruses in Harbin, China. Jpn J Infect Dis 2003 56 : 19 22.
19. Zhao SM, Jiang TL, Gao FX, Lu L, Zheng HQ, Hu J, Fan YH, Li B, Xiao RR, Yury K. Analysis of true voluntary blood donors with anti-HCV prevalence and implications for donor management in Chongqing, China. Transfus Med 2007 17 : 210 1.
20. Nainan OV, Lu L, Gao FX, Meeks E, Robertson BH, Margolis HS. Selective transmission of hepatitis C virus genotypes and quasispecies in humans and experimentally infected chimpanzees. J Gen Virol 2006 87 : 83 91.
21. Ji Y, Ren QH, Zhu ZY, Qu DM, Qiu ZK, Li JF, Mei H, Yan HY. Investigation and analysis of HCV infection in Chinese blood donors. Acta Acad Med Sinicae 1998 203 : 240 1.
22. Shi XL, Ren QH, Zhu ZY, Qu DM, Ji Y, Peng DH, Ni SQ. Hepatitis C virus infection in blood donors in the People's Republic of China. Transfusion 1999 39 : 913.
23. Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, Liu CL, Wang JX, Yao FZ, Zheng YR, Zhu FM, Tiemuer MH, Bai XH, Shan H. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Transfusion 2005 45 : 1816 22.
24. Shan H, Ren FR, Zhao HY, Zhang YZ, Wen GX, Yao FZ, Gao GJ, Yan LX, Jiang CF, Bai XH, Tiemuer MH, Tu YQ, Zhu FM, Zheng YR, Cui L, Liu CL, Gong XY, Lv QS, Zheng P, Ziermann R, Ness P, Wang JX. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing. Transfusion 2007 47 : 2011 6. (Pubitemid 47623970)
25. Shang G, Seed CR, Wang F, Nie D, Farrugia A. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 2007 47 : 529 39.
26. Glynn SA, Kleinman SH, Schreiber GB, Busch MP, Wright DJ, Smith JW, Nass CC, Williams AE. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991-1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000 284 : 229 35.
27. O'Brien SF, Fan W, Xi G, Yi QL, Goldman M, Fearon MA, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M, Delage G. Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies. Transfusion 2008 48 : 902 9.
28. Murphy EL, Brazman SM, Glynn SA, Ameti DY, Thomson RA, Williams AE, Nass CC. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology study (REDS). Hepatology 2000 31 : 756 62.
29. Alter MJ, Kuhnert WL, Finelli L, Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003 52 : 1 13.
30. Seeff LB, Hollinger FB, Alter HJ, Wright EC, Cain CM, Buskell ZJ, Ishak KG, Iber FL, Toro D, Samanta A, Koretz RL, Perrillo RP, Goodman ZD, Knodell RG, Gitnick G, Morgan TR, Schiff ER, Lasky S, Stevens C, Vlahcevic RZ, Weinshel E, Tanwandee T, Lin HJ, Barbosa L. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology 2001 33 : 455 63.
31. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, Manns MP, Rehermann B. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000 6 : 578 82.
32. Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, Schraut WW, Schirren CA, Waechtler M, Backmund M, Pape GR. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003 125 : 80 8.
33. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006 13 : 34 41.
34. Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott EP, Shaw-Stiffel T, Weston SJ, Thiede H, Wald A, Rosen HR. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 2007 196 : 1474 82.
35. Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, Shyamala V, Ray SC, Thomas DL. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 2005 40 : 951 8.
36. Santantonio T, Medda E, Ferrari C, Fabris P, Cariti G, Massari M, Babudieri S, Toti M, Francavilla R, Ancarani F, Antonucci G, Scotto G, Di Marco V, Pastore G, Stroffolini T. Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis 2006 43 : 1154 9.
37. Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J, EuroSIDA Study Group. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis 2008 198 : 1337 44.